Hicks R M, Wakefield J, Chowaniec J
Chem Biol Interact. 1975 Sep;11(3):225-33. doi: 10.1016/0009-2797(75)90101-5.
A sensitive rat model has been designed to detect potential weak bladder carcinogens or co-carcinogens. The test compound is given to animals which have received a single initiating, but non-carcinogenic, dose of N-methyl-N-nitrosourea (MNU). The model has been used to investigate two compounds currently under suspicion as weak bladder carcinogens, namely sodium saccharin and sodium cyclamate, and one compound known to be cytotoxic but not carcinogenic for the bladder epithelium namely cyclophosphamide. For comparison, these three compounds were also tested as solitary carcinogens in animals not pre-treated with MNU. At the very high dose levels used, sodium saccharin and sodium cyclamate were weak solitary carcinogens producing 4/253 and 3/228 bladder tumours respectively, and the first of these tumours did not appear for more than 80 weeks. When tested in the MNU/rat model more than half the animals receiving either sodium saccharin or sodium cyclamate developed bladder tumours from 10 weeks onwards. By contrast, cyclophosphamide failed to produce any tumours when tested either as a solitary carcinogen or in the MNU/rat model. It must be emphasized that the doses of saccharin and cyclamate used were far higher than those consumed by man, including diabetics, and these results should not be directly extrapolated to man without careful consideration of many other factors including negative epidemiological findings. The theoretical basis of the model is discussed and also the relevance, in terms of environmental human exposure, of detecting compounds which have a synergistic effect with other known bladder carcinogens. It appears that this model can be used to detect a carcinogenic or co-carcinogenic potential in compounds which are organotropic for the bladder more rapidly and with fewer animals than if the compounds are tested as solitary carcinogens by more conventional methods. It is suggested that it could be used to detect those compounds which require further investigation.
已设计出一种敏感的大鼠模型,用于检测潜在的弱膀胱致癌物或协同致癌物。将受试化合物给予已接受单次引发剂量但无致癌性的N-甲基-N-亚硝基脲(MNU)的动物。该模型已用于研究目前被怀疑为弱膀胱致癌物的两种化合物,即糖精钠和甜蜜素,以及一种已知对膀胱上皮细胞具有细胞毒性但无致癌性的化合物,即环磷酰胺。为作比较,这三种化合物也在未用MNU预处理的动物中作为单独的致癌物进行了测试。在所用的非常高剂量水平下,糖精钠和甜蜜素是弱单独致癌物,分别产生4/253和3/228个膀胱肿瘤,其中第一个肿瘤在80周以上才出现。当在MNU/大鼠模型中进行测试时,接受糖精钠或甜蜜素的动物中超过一半从10周起就出现了膀胱肿瘤。相比之下,环磷酰胺无论是作为单独的致癌物进行测试还是在MNU/大鼠模型中进行测试,都未能产生任何肿瘤。必须强调的是,所用的糖精和甜蜜素剂量远高于包括糖尿病患者在内的人类摄入量,在未仔细考虑包括负面流行病学研究结果在内的许多其他因素的情况下,这些结果不应直接外推至人类。讨论了该模型的理论基础,以及就人类环境暴露而言检测与其他已知膀胱致癌物具有协同作用的化合物的相关性。看来,与通过更传统方法将化合物作为单独致癌物进行测试相比,该模型可用于更快地检测对膀胱具有器官亲和性的化合物中的致癌或协同致癌潜力,且所需动物数量更少。建议可利用该模型检测那些需要进一步研究的化合物。